Trademark applications and grants for Syros Pharmaceuticals, Inc.. Syros Pharmaceuticals, Inc. has 6 trademark applications. The latest application filed is for "RAZTAMRI"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 35 CambridgePark Drive, 4th Floor Cambridge, MASSACHUSETTS UNITED STATES 02140 |
Patent Application | Date |
---|---|
INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) 20220305014 - 17/687259 Marineau; Jason J. ;   et al. | 2022-09-29 |
COMPOUNDS FOR THE MODULATION OF MYC ACTIVITY 20220048927 - 17/411965 Marineau; Jason J. ;   et al. | 2022-02-17 |
INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) 20220000890 - 16/962809 Marineau; Jason J. ;   et al. | 2022-01-06 |
INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) 20210403495 - 17/289861 Marineau; Jason J. ;   et al. | 2021-12-30 |
METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH NON-COVALENT INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) 20210401859 - 17/289873 Hodgson; John Graeme ;   et al. | 2021-12-30 |
NCAGE Code | 6W8S0 | SYROS PHARMACEUTICALS, INC. |
CAGE Code | 6W8S0 | SYROS PHARMACEUTICALS, INC. |
SEC | 0001556263 | Syros Pharmaceuticals, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.